According to the latest WHO data, as of 17:00 on the 15th, Beijing time, the cumulative number of confirmed cases of new coronary pneumonia outside China has exceeded 72,469. The WHO also stated that Europe has become the epicenter of the global epidemic. In addition to Europe, the United States, Japan and South Korea in Asia, and Iran in the Middle East are also facing severe epidemics.
In order to meet the needs of epidemic prevention and control, major epidemic countries have taken measures to expand the import of epidemic prevention materials. For example, on March 5, the US Trade Representative Office (USTR) issued an announcement to exempt more than 100 Chinese-imported medical-related products from 27 US companies. tariff.
In addition, according to Iran's "Economic Online" report, in order to encourage the import of masks, Iran has reduced the mask import rate from 55% to 5%.
WHO: Global production capacity of protective materials should be increased by 40% to meet the needs of the New Champions
The World Health Organization (WHO) recently issued an alert saying that due to rising demand, panic buying, hoarding and abuse, the global supply of personal protective equipment (PPE) has been increasingly disrupted, making people face the threat of new coronavirus and other infectious diseases.
"Without a safe supply chain, the risks faced by healthcare professionals around the world are real. Industry and governments must act quickly to increase supply, ease export restrictions, and take measures to stop speculation and hoarding." WHO Director-General Tan Seid said: "If we don't protect the health care workers first, we can't stop the new coronavirus outbreak."
So far, WHO has shipped nearly 500,000 sets of personal protective equipment to 47 countries, but the supply is rapidly drying up.
According to WHO's model estimates, it is estimated that 89 million medical masks are required per month to respond to the new coronavirus. As for medical gloves, this demand is as high as 76 million, while the international demand for goggles is 1.6 million per month.
In its recent guidance, WHO called for the rational use of personal protective equipment in the medical environment and effective management of the supply chain.
WHO has partnered with governments, manufacturers and the Pandemic Supply Chain Network to help increase production and guarantee the supply of personal protective equipment to severely affected and risky countries.
To meet the growing global demand, WHO estimates that the global manufacturing capacity for protective materials must increase by 40%.
Enterprises expand the production capacity of masks and raw materials
At present, many listed companies around the world are expanding production of meltblown nonwoven fabrics. China stated that with the gradual expansion of the overseas epidemic, China has exported more than 3,000 tons of melt-blown material Y381H to India, Vietnam and other countries since February 2020 on the premise of ensuring the production of domestic medical masks and other medical protective equipment.
On March 13th, Chinese companies released the "Announcement on Increasing Meltblown Nonwoven Fabric Production Capacity", saying that there have been three new meltblown nonwoven fabric production lines, and the daily production capacity has been increased from 6 tons to 12 tons.
Midland New Materials also announced on the 13th that it intends to transform high-end melt-blown materials and melt-blown non-woven fabrics to improve production capacity.
Some Chinese companies also publicly stated that after the outbreak, their mask production was carried out "7x24", but the production and supply could not keep up with demand, and they were looking for ways to expand production capacity.
According to statistics from the Bureau of Statistics, from January to February, the output of industrial enterprises above designated size shows that the output of Chinese mask products increased by 2.9 times year-on-year. Judging from the data on February 29, the average daily output of masks has reached 116 million, indicating that our strong supply capacity has not been affected, which strongly supports the supply of medical supplies.
Related medical device companies have also received overseas orders
China Trade recently said that it has received more overseas orders, and the infrared thermometer products of Chinese companies have been in short supply since the outbreak, maintaining a zero inventory status.
Allegedly, "New Coronavirus nucleic acid detection kit has been issued to more than 30 countries and regions, including donations and overseas orders."
Received overseas purchase orders since February 24. Recently, the Italian government has urgently procured the first batch of nearly 10,000 anti-epidemic equipment from Chinese medical services, including monitors and other products.
In vitro diagnostic company Mike Bio also issued an announcement on March 2 that its new coronavirus detection kit has recently received overseas orders from Iran and other countries.
Eastern Bio, which is also an in vitro diagnostic industry, has also signed emergency sales orders with Austria, Romania, Italy, Greece and other countries. At present, the orders of EU customers in the hands of Orient Biotech are approximately USD 35,850.
Medical equipment company Libang Instruments disclosed in the newly released "Investor Relations Activity Record Form" that Italy immediately placed more than 20 blood gas product orders with the company after the outbreak of the new crown epidemic.
Bao Laite, which produces monitors, said that "the company made a pre-judgment early". At present, Bao Laite has received more than 1,000 monitor orders from Italy.
Disposable PVC examination gloves.
On March 5th, he also said on the interactive platform: "Priority guarantees domestic demand, overseas orders will be extended to some extent. With the company's subsequent release of 6 billion gloves production capacity and the stability of the domestic epidemic, overseas orders are expected to increase.
Global protective materials need to increase by 40% Chinese medical and anti-epidemic materials companies actively respond
|
163.com